<DOC>
	<DOCNO>NCT02148653</DOCNO>
	<brief_summary>Main scientific question : A previous intervention anti-inflammatory multifunctional dietary portfolio ( MFD ) show remarkable reduction cardiometabolic ( CM ) risk marker compare well-designed control diet . The study perform weight maintenance condition healthy subject 4w crossover design ( Tovar et al. , 2012 ) . MFD consumption also result improved cognitive performance 4 week ( Nilsson et al. , 2013 ) . The present project study preventive potential MFD , use unique property identification new biomarkers evaluate potential role alteration gut microbiota . MFD test healthy risk subject randomize parallel design eight-week intervention test control diet , respectively , allow weight loss . Assessment standard anthropometric/biochemical marker CM risk , metabolomics analysis appetite regulate hormone evaluation also plan . Associations gut microbiota composition measure CM risk also include . The project provide unique opportunity identify mechanisms metabolic impact MFD , exploitation innovative food and/or dietary concept . Central hypothesis : The CM-preventive potential MFD may boost medium-term trial condition allow body weight reduction . Expected additional benefit may record reduce value conventional CM-related parameter , marker modify gut microbiota composition specific change blood metabolite profile . Objectives : - To improve effect MFD biochemical/anthropometric CM risk marker healthy subject administer diet condition allow weight reduction . - To identify MFD-related change gut microbiota associate improved CM risk marker . - To assess MFD-related modification metabolic pathway , study metabolomics approach , correlate conventional clinical outcome , aim identify new marker alter metabolic risk .</brief_summary>
	<brief_title>An Antiinflammatory Diet Modulator Cardiometabolic Risk Body Weight Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Normal fast blood glucose ( max 6.1 mmol /l ) BMI 25 32 Kg/m2 treatment hypercholesterolemia treatment hypertension history cardiovascular complication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>73 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cardiometabolic risk</keyword>
	<keyword>Diet</keyword>
	<keyword>Dietary prevention</keyword>
	<keyword>Functional diet</keyword>
	<keyword>Functional food</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Overweight</keyword>
</DOC>